Schnall BM (2013) Pediatric nasolacrimal duct obstruction. Curr Opin Ophthalmol 24:421–424
Pascale A, Marchesi N, Marelli C et al (2018) Microbiota and metabolic diseases. Endocrine 61:357–371
Article CAS PubMed Google Scholar
Skonieczna-Zydecka K, Janda K, Kaczmarczyk M et al (2020) The effect of probiotics on symptoms, gut microbiota and inflammatory markers in infantile colic: a systematic review, meta- analysis and meta-regression of randomized controlled trials. J Clin Med 9:999
Article CAS PubMed PubMed Central Google Scholar
Belizário JE, Faintuch J, Garay-Malpartida M (2018) Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediat Inflamm 2018:2037838
Madan P, Daigavane S (2018) Congenital nasolacrimal duct obstruction: clinical, microbiological and management in a tertiary health care centre in central India- A descriptive study. Indian J Clin Exp Ophthalmol 4:217–220
Zheng XY, Choy BNK, Zhou MM et al (2020) Lacrimal sac bacteriology and susceptibility pattern in infants with congenital nasolacrimal duct obstruction in the 1st year of life: a cross-sectional study. BMC Pediatr 20:465
Article CAS PubMed PubMed Central Google Scholar
Natarajan K, Kasturi N, Sistla S (2022) Assessment of perinatal clinical characteristics, perinatal risk factors, and microbial profile in congenital nasolacrimal duct obstruction in a tertiary care center: A descriptive study. Korean J Ophthalmol 36:366–373
Article CAS PubMed PubMed Central Google Scholar
Bareja U, Ghose S (1990) Clinicobacteriological correlates of congenital dacryocystitis. Indian J Ophthalmol 38:66–69
Muthumalai M, Alam MS, Shrirao N et al (2022) A case- control study to determine the microbiological spectrum and antibiotic sensitivity patterns in congenital nasolacrimal duct obstruction. J Curr Ophthalmol 34:251–256
Article PubMed PubMed Central Google Scholar
Prokosch V, Prokosch JE, Promesberger J et al (2010) Bacteriology of occluded nasolacrimal ducts in infants. Klin Monbl Augenheilkd 227:585–588
Article CAS PubMed Google Scholar
Al-Faky YH, Naeem T, Al-Sobaie N et al (2012) Value of microbiology study in congenital nasolacrimal duct obstruction. Saudi J Ophthalmol 26:223–228
Article PubMed PubMed Central Google Scholar
Usha K, Smitha S, Shah N et al (2006) Spectrum and the susceptibilities of microbial isolates in cases of congenital nasolacrimal duct obstruction. J AAPOS 10:469–472
Jian C, Luukkonen P, Yki-Järvinen H et al (2020) Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling. PLoS ONE 15:e0227285
Article CAS PubMed PubMed Central Google Scholar
Chong J, Liu P, Zhou G et al (2020) Using microbiome analyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc 15:799–821
Article CAS PubMed Google Scholar
Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361:512–519
Bilge DA (2019) Mode of delivery, birth weight and the incidence of congenital nasolacrimal duct obstruction. Int J Ophthalmol 12:1134–1138
Kuhli-Hattenbach C, Lüchtenberg M, Hofmann C et al (2016) Increased prevalence of congenital dacryostenosis following cesarean section. Ophthalmologe 113:675–683
Article CAS PubMed Google Scholar
Spaniol K, Stupp T, Melcher C (2015) Association between congenital nasolacrimal duct obstruction and delivery by cesarean section. Am J Perinatol 32:271–276
Alakus MF, Dag U, Balsak S et al (2020) Is there an association between congenital nasolacrimal duct obstruction and cesarean delivery? Eur J Ophthalmol 30:1228–1231
Palo M, Gupta S, Naik MN et al (2018) Congenital nasolacrimal duct obstruction and its association with the mode of birth. J Pediatr Ophthalmol Strabismus 55:266–268
Tavakoli M, Osigian CJ, Saksiriwutto P et al (2018) Association between congenital nasolacrimal duct obstruction and mode of delivery at birth. J AAPOS 22:381–385
Rutayisire E, Huang K, Liu Y et al (2016) The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol 16:86
Article PubMed PubMed Central Google Scholar
Montoya-Williams D, Lemas DJ, Spiryda L et al (2018) The neonatal microbiome and its partial role in mediating the association between birth by cesarean section and adverse pediatric outcomes. Neonatology 114:103–111
Curragh DS, Bassiouni A, Macias-Valle L et al (2020) The microbiome of the nasolacrimal system and its role in nasolacrimal duct obstruction. Ophthalmic Plast Reconstr Surg 36:80–85
Ali MJ (2022) Functional metagenomic profile of the lacrimal sac microbial communities in primary acquired nasolacrimal duct obstruction: the Lacriome paper 2. Eur J Ophthalmol 32:2059–2066
Ali MJ (2023) Metagenomics of the lacrimal sac in primary acquired nasolacrimal duct obstruction: the Lacriome paper 1. Br J Ophthalmol 107:147–150
Ali MJ (2024) Fungal microbiome (mycobiome) and virome of the lacrimal sac in patients with PANDO: the lacriome paper 5. Br J Ophthalmol 108:317–322
Pescosolido N, Imperatrice B, Karavitis P (2008) Ocular disorders secondary to systemic disease and the potential role of carnitines. Drugs R D 9:15–22
Article CAS PubMed Google Scholar
Pescosolido N, Imperatrice B, Karavitis P (2008) The aging eye and the role of L-carnitine and its derivatives. Drugs R D 9:3–14
Article CAS PubMed Google Scholar
Hua X, Su Z, Deng R et al (2015) Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress. Curr Eye Res 40:657–667
留言 (0)